CCP
BIIB icon

Cardan Capital Partners’s Biogen BIIB Stock Holding History

Cardan Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3.63M Sell
12,809
-89
-0.7% -$29.2K 0.41% 75
2021
Q2 		$4.47M Sell
12,898
-257
-2% -$77.9K 0.5% 64
2021
Q1 		$3.68M Buy
13,155
+286
+2% +$77.1K 0.44% 70
2020
Q4 		$3.15M Sell
12,869
-61
-0.5% -$15.7K 0.39% 78
2020
Q3 		$3.67M Buy
12,930
+607
+5% +$169K 0.49% 68
2020
Q2 		$3.3M Buy
12,323
+43
+0.4% +$12.9K 0.47% 74
2020
Q1 		$3.88M Sell
12,280
-277
-2% -$84.1K 0.65% 42
2019
Q4 		$3.73M Buy
12,557
+273
+2% +$75.7K 0.5% 57
2019
Q3 		$2.86M Buy
12,284
+551
+5% +$128K 0.41% 66
2019
Q2 		$2.74M Buy
11,733
+425
+4% +$98.1K 0.42% 66
2019
Q1 		$2.67M Sell
11,308
-58
-0.5% -$18.3K 0.43% 64
2018
Q4 		$3.42M Sell
11,366
-51
-0.4% -$16.3K 0.6% 49
2018
Q3 		$4.03M Sell
11,417
-95
-0.8% -$32.7K 0.63% 44
2018
Q2 		$3.34M Buy
11,512
+11
+0.1% +$3.09K 0.55% 51
2018
Q1 		$3.15M Buy
11,501
+45
+0.4% +$14K 0.52% 53
2017
Q4 		$3.65M Sell
11,456
-30
-0.3% -$9.62K 0.69% 47
2017
Q3 		$3.6M Buy
11,486
+43
+0.4% +$12.7K 0.72% 46
2017
Q2 		$3.1M Sell
11,443
-285
-2% -$75.4K 0.6% 51
2017
Q1 		$3.21M Sell
11,728
-25
-0.2% -$7.07K 0.67% 44
2016
Q4 		$3.33M Sell
11,753
-108
-0.9% -$32K 0.74% 44
2016
Q3 		$3.71M Sell
11,861
-179
-1% -$53K 0.83% 42
2016
Q2 		$2.91M Buy
12,040
+2
+0% +$527 0.72% 43
2016
Q1 		$3.13M Buy
12,038
+4,180
+53% +$1.1M 0.78% 44
2015
Q4 		$2.41M Buy
+7,858
New +$2.26M 1.03% 33

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cardan Capital Partners's BIIB Position: Q3 2021 in Review

Cardan Capital Partners reduced its Biogen (BIIB) stake by 0.69% in Q3 2021, selling an estimated $29.2K and leaving 12,809 shares worth $3.63M. The position accounts for 0.41% of the portfolio, ranked #75.

Cardan Capital Partners first reported a position in BIIB in Q4 2015 and has held it in 24 quarters since. The position peaked at $4.47M in Q2 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Cardan Capital Partners held 12,809 shares of Biogen worth $3.63M as of Q3 2021.
  • Cardan Capital Partners sold 89 Biogen shares in Q3 2021, an estimated $29.2K.
  • Biogen made up 0.41% of Cardan Capital Partners's portfolio in Q3 2021, its #75 holding.
  • Cardan Capital Partners first reported a position in Biogen in Q4 2015 and has held it in 24 quarters since.
  • Cardan Capital Partners's Biogen position peaked at $4.47M in Q2 2021.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.